At a glance
ClinicalIndex Comparison RecordN/ACompleted· 831 enrolled
Drug / intervention
Vitrectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Incidence and Factors Related to Macular Hole Reopening
In Brief
An observational study evaluating Vitrectomy for Vitrectomy. Completed, enrolled 831 participants across 1 site.
Detailed Summary
The purpose of this investigation was to determine the incidence and the factors that cause a reopening of a macular hole (MH) after a surgical closure.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVitrectomy
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
19901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 1990
Primary CompletionDec 2008
First PostedJun 2009
TodayJul 2026
First PostedJun 25, 2009
Enrollment StartOct 1, 1990
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 18.2 yearsPosted 17.0 years ago
Interventions
Vitrectomyprocedure
Patients underwent vitrectomy with or without internal limiting membrane (ILM) peeling for an idiopathic full-thickness macular holes. Simultaneous phacoemulsification with intraocular lens implantation was performed on all phakic patients who were \>40-years-of-age.